Archive for the ‘Proteomics’ Category

Pancreatic cancer genomes: Axon guidance pathway genes – aberrations revealed

Posted in Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics,Computational Biology/Systems and Bioinformatics, Genome Biology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, Genomic Testing: Methodology for Diagnosis, Liver & Digestive Diseases Research, Medical and Population Genetics, Metabolomics, Molecular Genetics & Pharmaceutical, Personalized Medicine & Genomic Research, Population Health Management, Nutrition and Phytochemistry, Proteomics, Statistical Methods for Research Evaluation, Technology Transfer: Biotech and Pharmaceutical, tagged cancer, Disease and Conditions, Garvan Institute of Medical Research, KRAS, Nature (journal), Pancreatic cancer on October 24, 2012 | Leave a Comment »

Reporter: Aviva Lev-Ari, PhD, RN     Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes   Andrew V. Biankin, Nicola Waddell, Karin S. Kassahn, Marie-Claude Gingras, Lakshmi B. Muthuswamy, Amber L. Johns, David K. Miller, Peter J. Wilson, Ann-Marie Patch, Jianmin Wu, David K. Chang, Mark J. Cowley, Brooke B. Gardiner, Sarah Song, Ivon Harliwong, Senel [...]

Read Full Post »

Dopamine Gene Variant Predictive of Placebo Response in IBS Patients

Posted in Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics, Clinical Trials and IRB related issues,Computational Biology/Systems and Bioinformatics, Disease Biology, Small Molecules in Development of Therapeutic Drugs, FDA Regulatory Affairs, Genome Biology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, Genomic Testing: Methodology for Diagnosis, Human Immune System in Health and in Disease,Liver & Digestive Diseases Research, Medical and Population Genetics, Metabolomics,Molecular Genetics & Pharmaceutical, Nutrigenomics, Personalized Medicine & Genomic Research, Pharmaceutical R&D Investment, Proteomics, Technology Transfer: Biotech and Pharmaceutical, tagged Clinical trial, Beth Israel Deaconess Medical Center, Genetic marker, PLoS ONE, Catechol-O-methyl transferase, Irritable bowel syndrome, Placebo on October 24, 2012 | Leave a Comment »

Reporter: Aviva Lev-Ari, PhD, RN   Study Finds Dopamine Gene Variant Predictive of Placebo Response in IBS Patients October 24, 2012   By Molika Ashford Researchers led by a group at Beth Israel Deaconess Medical Center have identified a genetic marker associated with the placebo effect in patients with irritable bowel syndrome. According to the group, the [...]

Read Full Post »

Metabolite Identification Combining Genetic and Metabolic Information: Genetic association links unknown metabolites to functionally related genes

Posted in Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, Cardiovascular Pharmaceutical Genomics, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics,Computational Biology/Systems and Bioinformatics, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Genome Biology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, Genomic Testing: Methodology for Diagnosis, Liver & Digestive Diseases Research, Medical and Population Genetics, Metabolomics, Molecular Genetics & Pharmaceutical, Origins of Cardiovascular Disease, Personalized Medicine & Genomic Research, Pharmaceutical R&D Investment,Population Health Management, Genetics & Pharmaceutical, Proteomics, Statistical Methods for Research Evaluation, Technology Transfer: Biotech and Pharmaceutical, tagged Research Triangle Park, Genome-wide association study, Helmholtz Zentrum München on October 22, 2012 | 1 Comment »

Reporter: Aviva Lev-Ari, PhD, RN  Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information Jan Krumsiek1, Karsten Suhre1,2, Anne M. Evans3, Matthew W. Mitchell3, Robert P. Mohney3, Michael V. Milburn3, Brigitte Wägele1,4, Werner Römisch-Margl1, Thomas Illig5,6, Jerzy Adamski7,8, Christian Gieger9, Fabian J. Theis1,10, Gabi Kastenmüller1*   1 Institute of Bioinformatics [...]

Read Full Post »

Advances in Separations Technology for the “OMICs” and Clarification of Therapeutic Targets

Posted in Pharmaceutical Industry Competitive Intelligence, Personalized Medicine & Genomic Research, International Global Work in Pharmaceutical, Pharmaceutical R&D Investment, CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Computational Biology/Systems and Bioinformatics, Genome Biology,Chemical Biology and its relations to Metabolic Disease, Biological Networks, Gene Regulation and Evolution, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Population Health Management, Genetics & Pharmaceutical, Alzheimer's Disease,Pharmacotherapy, Proteomics, Bio Instrumentation in Experimental Life Sciences Research, Biomarkers & Medical Diagnostics, Metabolomics, Nutrition, Nutrigenomics,Population Health Management, Nutrition and Phytochemistry, Molecular Genetics & Pharmaceutical, Technology Transfer: Biotech and Pharmaceutical, Imaging-based Cancer Patient Management, Nanotechnology for Drug Delivery, tagged ABPP, activity-based probes, adenosine-affinity chromatography, Affinity Chromatography, Aptamer affinity chromatography, Aptamer-based delivery system, Aptamer-based multiplexed technology, Biomarker discovery, BRCT domains, disease, drug discovery, expanded DNA alphabet, g-secretase, health, KIAA1362, metabolism, Metabolomics, Nutrigenomic,Nutrition, Omics, presenilin-like proteases, Proteomics, Pyruvate Kinase, selective inhibitors, signal peptide peptidases on October 22, 2012 | 1 Comment »

Curator, Reporter, EAW:  Larry H Bernstein, MD, FCAP Advances in Separations Technology for the “OMICs” and Clarification of Therapeutic Targets This discussion is a continuation of an earlier piece on the technologic framework for , proteomics, nutrigenomics, and translational medicine. The last decade has seen the emergence of a genomic science that is changing the [...]

Read Full Post »

A Prion Like-Protein, Protein Kinase Mzeta and Memory Maintenance

Posted in Cell Biology, Signaling & Cell Circuits, Genome Biology, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Alzheimer's Disease, Proteomics,Innovations in Neurophysiology & Neuropsychology, tagged Ebonyi StateUniversity, Prion,protein kinase, memory, learning, neuronal plasticity, behavioral performance, neuronal astrocyte, memory encoding, synaptic function on October 19, 2012 | Leave a Comment »

Larry H Bernstein, MD, FCAP, Reporter An interesting paper recently published. I only show abstract and part of introduction. Available online http://www.interesjournals.org/JMMS Copyright © 2012 International Research Journals Review Martin Ezeani, Maxwell Omabe, J.C. Onyeanusi, I.N. Nnatuanya, Elom S.O. *1Department of Neurosciences, University of Sussex UK *2Molecular Pathology Division, Department of Medical Laboratory Sciences, Faculty [...]

Read Full Post »

Gene Trap Mutagenesis in Reproductive Research

Posted in Pharmaceutical Analytics, Pharmaceutical Industry Competitive Intelligence,Personalized Medicine & Genomic Research, Pharmaceutical R&D Investment, Chemical Genetics, Cell Biology, Signaling & Cell Circuits, Computational Biology/Systems and Bioinformatics, Medical and Population Genetics, Genome Biology, Biological Networks, Gene Regulation and Evolution, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Population Health Management, Genetics & Pharmaceutical,Reproductive Biology & Bio Instrumentation, Proteomics, Bio Instrumentation in Experimental Life Sciences Research, Biomarkers & Medical Diagnostics, Molecular Genetics & Pharmaceutical, Stem Cells for Regenerative Medicine, Genomic Testing: Methodology for Diagnosis, Technology Transfer: Biotech and Pharmaceutical, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, taggedgene, genetics, genome, mutation, microarray, DNA, Nucleic acid sequence, reproductive research, gene trap mutagenesis, Dr. Sudipta Saha, Single-nucleotide polymorphism on October 18, 2012 | 1 Comment »

Reporter and Curator: Dr. Sudipta Saha, Ph.D. With the completion of the mapping of the human genome, we now have access to all the DNA sequence information responsible for human biology. Together with microarray technology, we are ushering in a new era in reproductive medicine—the era of Reproductive Genomics. Whole genome microarray analysis of the [...]

Read Full Post »

Is the Warburg Effect the cause or the effect of cancer: A 21st Century View?

Posted in Biological Networks, Gene Regulation and Evolution, CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Genome Biology, Imaging-based Cancer Patient Management, International Global Work in Pharmaceutical, Liver & Digestive Diseases Research, Metabolomics, Molecular Genetics & Pharmaceutical,Nutrition, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical, Population Health Management, Nutrition and Phytochemistry, Proteomics, Stem Cells for Regenerative Medicine, Technology Transfer: Biotech and Pharmaceutical, tagged Adenosine triphosphate, ATP, Glycolysis, Hypoxia-inducible factors, Kreb, Lactate dehydrogenase,Mammalian target of rapamycin, Mitochondrion, Warburg Effect on October 17, 2012 | 6 Comments »

Is the Warburg Effect the cause or the effect of cancer: A 21st Century View?   Larry H. Bernstein, MD,, FCAP, Curator, EAW, A Critical Review   What is the Warburg effect? “Warburg Effect” describes the preference of glycolysis and lactate fermentation rather than oxidative phosphorylation for energy production in cancer cells. Mitochondrial metabolism is [...]

Read Full Post »

Statins’ Nonlipid Effects on Vascular Endothelium through eNOS Activation

Posted in 'Nitric Oxide in Health and Disease', Biological Networks, Gene Regulation and Evolution, Cardiovascular Pharmaceutical Genomics, Cell Biology, Signaling & Cell Circuits, Disease Biology, Small Molecules in Development of Therapeutic Drugs, HTN,Metabolomics, Molecular Genetics & Pharmaceutical, Origins of Cardiovascular Disease,Pharmacotherapy Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease,Proteomics, tagged eNOS, vascular relaxation, vasorelaxation, micro and macrocirculationon October 8, 2012 | 7 Comments »

Curator, Author,Writer, Reporter: Larry Bernstein, MD, FCAP   Categories of Research: Disease biology, Cell Biology and Cell Signaling, Biological Networks and Gene Regulation, Pharmacotherapy of Cardiovascular Disease, Nitric Oxide, HMG Co A inhibitors, Endothelial Receptor, Hypertension, Therapeutic Targets Introduction Statins have an effect on the vascular endothelium, which plays an important role in the development [...]

Read Full Post »

Expanding the Genetic Alphabet and linking the genome to the metabolome

Posted in Pharmaceutical Analytics, Pharmaceutical Industry Competitive Intelligence,Personalized Medicine & Genomic Research, Pharmaceutical R&D Investment, CANCER BIOLOGY & Innovations in Cancer Therapy, Chemical Genetics, Cell Biology, Signaling & Cell Circuits, Computational Biology/Systems and Bioinformatics, Medical and Population Genetics, Genome Biology, Chemical Biology and its relations to Metabolic Disease,Biological Networks, Gene Regulation and Evolution, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Population Health Management, Genetics & Pharmaceutical, Liver & Digestive Diseases Research, Proteomics, Bio Instrumentation in Experimental Life Sciences Research, Biomarkers & Medical Diagnostics, Metabolomics,Nutrition, Nutrigenomics, Population Health Management, Nutrition and Phytochemistry,Systemic Inflammatory Response Related Disorders, Molecular Genetics & Pharmaceutical, Genomic Testing: Methodology for Diagnosis, Technology Transfer: Biotech and Pharmaceutical, Scientist: Career considerations, tagged adenine, ATP,biodiversity, cancer, Cancer Genome Atlas, cystathionine beta synthase, cytosine, DNA,fumarate, gene modification, genetic code, genetic engineering, genetics, genome,guanine, H2S, homocysteine, inosine, malnutrition, metabolome, methionine, Nature (journal), Nature Chemical Biology, Nucleic acid double helix, nucleosides, oncometabolite,oxidative stress, proteome, regulatory pathways, S-adenosylmethionine, Scripps Research Institute, Sulfur, synthetic nucleotides, thymidine, Warburg Effect, Watson-Crick Model,xanthine on September 24, 2012 | 6 Comments »

Reporter: Curator (Nutrigenomic and Nutriceuticals) Larry Bernstein, MD, FACP Unlocking the diversity of genomic expression within tumorigenesis and “tailoring” of therapeutic options   1. Reshaping the DNA landscape between diseases and within diseases by the linking of DNA to treatments In the NEW York Times of 9/24,2012 Gina Kolata reports on four types of breast [...]

Read Full Post »

NATIONAL CENTERS FOR BIOMEDICAL COMPUTING: Resources

Posted in Bio Instrumentation in Experimental Life Sciences Research, Biomarkers & Medical Diagnostics, Cell Biology, Signaling & Cell Circuits, Computational Biology/Systems and Bioinformatics, FDA Regulatory Affairs, Genome Biology, Genomic Testing: Methodology for Diagnosis, Molecular Genetics & Pharmaceutical, Personalized Medicine & Genomic Research, Population Health Management, Genetics & Pharmaceutical,Proteomics, Scientist: Career considerations, Statistical Methods for Research Evaluation,Technology Transfer: Biotech and Pharmaceutical, tagged genetics, genomics, National Institutes of Health, Aviva Lev-Ari, Brigham and Women's Hospital, Biology, Stanford University, systems biology, Bioinformatics, National Centers for Biomedical Computing,Cellular network on September 20, 2012 | Leave a Comment »

  Reporter: Aviva Lev-Ari, PhD, RN NATIONAL CENTERS FOR BIOMEDICAL COMPUTING An overarching approach to several disciplines: Genomics Major research areas of Genomics: 2.1 Bacteriophage genomics 2.2 Cyanobacteria genomics 2.3 Human genomics 2.4 Metagenomics 2.5 Pharmacogenomics Other Genomics related subdisciplines: Computational genomics Epigenomics Whole genome sequencing Functional genomics Genomics of domestication Immunomics Metagenomics Nitrogenomics Personal genomics Proteomics Psychogenomics The Biomedical Computing [...]

Read Full Post »

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

CSV publication Dr. ehab aboueladab

Authors,Title,Publication,Volume,Number,Pages,Year,Publisher

Brandt, B.; Büchse, T.; Abou-Eladab, E.F.; Tiedge, M.; Krause, E.; Jeschke, U.; Walzel, H.; ,Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes,Histochemistry and cell biology,129,5,599-609,2008,Springer

Walzel, H.; Fahmi, A.A.; Eldesouky, M.A.; Abou-Eladab, E.F.; Waitz, G.; Brock, J.; Tiedge, M.; ,Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes,Glycobiology,16,12,1262-1271,2006,Soc Glycobiology

Brandt, B.; Abou-Eladab, EF; Tiedge, M.; Walzel, H.; ,Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death,Cell death & disease,1,2,e23,2010,Nature Publishing Group

Jagannadham, M.V.; Abou-Eladab, E.F.; Kulkarni, H.M.; ,Identification of outer membrane proteins from an Antarctic bacterium Pseudomonas syringae Lz4W,Molecular & Cellular Proteomics,10,6,,2011,ASBMB

Abdel Malak, C.A.; Abou El Adab, I.F.G.; Vukashinovic, V.; Zalunin, I.A.; Timokhina, E.A.; Lavrenova, G.I.; Stepanov, V.M.; ,Buffalo (< i> Bos Buffali L.</i>) chymosin purification and properties,Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology,113,1,57-62,1996,Elsevier

Abou-Eladab, E.F.; Idris, M.M.; Jagannadham, M.V.; ,Evaluation of protein preparations from bacteria using proteomics approaches: Application to an Antarctic bacterium Pseudomonas syringae,,,,,,

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

RefMan publication Dr ehab aboueladab

TY  - JOUR
T1  - Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes
A1  - Brandt, B.
A1  - B├╝chse, T.
A1  - Abou-Eladab, E.F.
A1  - Tiedge, M.
A1  - Krause, E.
A1  - Jeschke, U.
A1  - Walzel, H.
JO  - Histochemistry and cell biology
VL  - 129
IS  - 5
SP  - 599
EP  - 609
SN  - 0948-6143
Y1  - 2008
PB  - Springer
ER  -


TY  - JOUR
T1  - Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes
A1  - Walzel, H.
A1  - Fahmi, A.A.
A1  - Eldesouky, M.A.
A1  - Abou-Eladab, E.F.
A1  - Waitz, G.
A1  - Brock, J.
A1  - Tiedge, M.
JO  - Glycobiology
VL  - 16
IS  - 12
SP  - 1262
EP  - 1271
SN  - 0959-6658
Y1  - 2006
PB  - Soc Glycobiology
ER  -


TY  - JOUR
T1  - Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
A1  - Brandt, B.
A1  - Abou-Eladab, EF
A1  - Tiedge, M.
A1  - Walzel, H.
JO  - Cell death & disease
VL  - 1
IS  - 2
SP  - e23
Y1  - 2010
PB  - Nature Publishing Group
ER  -


TY  - JOUR
T1  - Identification of outer membrane proteins from an Antarctic bacterium Pseudomonas syringae Lz4W
A1  - Jagannadham, M.V.
A1  - Abou-Eladab, E.F.
A1  - Kulkarni, H.M.
JO  - Molecular & Cellular Proteomics
VL  - 10
IS  - 6
SN  - 1535-9476
Y1  - 2011
PB  - ASBMB
ER  -


TY  - JOUR
T1  - Buffalo (< i> Bos Buffali L.</i>) chymosin purification and properties
A1  - Abdel Malak, C.A.
A1  - Abou El Adab, I.F.G.
A1  - Vukashinovic, V.
A1  - Zalunin, I.A.
A1  - Timokhina, E.A.
A1  - Lavrenova, G.I.
A1  - Stepanov, V.M.
JO  - Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
VL  - 113
IS  - 1
SP  - 57
EP  - 62
SN  - 1096-4959
Y1  - 1996
PB  - Elsevier
ER  -


TY  - JOUR
T1  - Evaluation of protein preparations from bacteria using proteomics approaches: Application to an Antarctic bacterium Pseudomonas syringae
A1  - Abou-Eladab, E.F.
A1  - Idris, M.M.
A1  - Jagannadham, M.V.
ER  -

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

BibTeX for Dr ehab aboueladab

@article{brandt2008galectin,
  title={Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes},
  author={Brandt, B. and B{\"u}chse, T. and Abou-Eladab, E.F. and Tiedge, M. and Krause, E. and Jeschke, U. and Walzel, H.},
  journal={Histochemistry and cell biology},
  volume={129},
  number={5},
  pages={599--609},
  year={2008},
  publisher={Springer}
}

@article{walzel2006effects,
  title={Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes},
  author={Walzel, H. and Fahmi, A.A. and Eldesouky, M.A. and Abou-Eladab, E.F. and Waitz, G. and Brock, J. and Tiedge, M.},
  journal={Glycobiology},
  volume={16},
  number={12},
  pages={1262--1271},
  year={2006},
  publisher={Soc Glycobiology}
}

@article{brandt2010role,
  title={Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death},
  author={Brandt, B. and Abou-Eladab, EF and Tiedge, M. and Walzel, H.},
  journal={Cell death \& disease},
  volume={1},
  number={2},
  pages={e23},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{jagannadham2011identification,
  title={Identification of outer membrane proteins from an Antarctic bacterium Pseudomonas syringae Lz4W},
  author={Jagannadham, M.V. and Abou-Eladab, E.F. and Kulkarni, H.M.},
  journal={Molecular \& Cellular Proteomics},
  volume={10},
  number={6},
  year={2011},
  publisher={ASBMB}
}

@article{abdel1996buffalo,
  title={Buffalo (< i> Bos Buffali L.</i>) chymosin purification and properties},
  author={Abdel Malak, C.A. and Abou El Adab, I.F.G. and Vukashinovic, V. and Zalunin, I.A. and Timokhina, E.A. and Lavrenova, G.I. and Stepanov, V.M.},
  journal={Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology},
  volume={113},
  number={1},
  pages={57--62},
  year={1996},
  publisher={Elsevier}
}

@article{abouevaluation,
  title={Evaluation of protein preparations from bacteria using proteomics approaches: Application to an Antarctic bacterium Pseudomonas syringae},
  author={Abou-Eladab, E.F. and Idris, M.M. and Jagannadham, M.V.}
}

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

EndNote -publication Dr ehab aboueladab

%0 Journal Article
%T Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes
%A Brandt, B.
%A B├╝chse, T.
%A Abou-Eladab, E.F.
%A Tiedge, M.
%A Krause, E.
%A Jeschke, U.
%A Walzel, H.
%J Histochemistry and cell biology
%V 129
%N 5
%P 599-609
%@ 0948-6143
%D 2008
%I Springer


%0 Journal Article
%T Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes
%A Walzel, H.
%A Fahmi, A.A.
%A Eldesouky, M.A.
%A Abou-Eladab, E.F.
%A Waitz, G.
%A Brock, J.
%A Tiedge, M.
%J Glycobiology
%V 16
%N 12
%P 1262-1271
%@ 0959-6658
%D 2006
%I Soc Glycobiology


%0 Journal Article
%T Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
%A Brandt, B.
%A Abou-Eladab, EF
%A Tiedge, M.
%A Walzel, H.
%J Cell death & disease
%V 1
%N 2
%P e23
%D 2010
%I Nature Publishing Group


%0 Journal Article
%T Identification of outer membrane proteins from an Antarctic bacterium Pseudomonas syringae Lz4W
%A Jagannadham, M.V.
%A Abou-Eladab, E.F.
%A Kulkarni, H.M.
%J Molecular & Cellular Proteomics
%V 10
%N 6
%@ 1535-9476
%D 2011
%I ASBMB


%0 Journal Article
%T Buffalo (< i> Bos Buffali L.</i>) chymosin purification and properties
%A Abdel Malak, C.A.
%A Abou El Adab, I.F.G.
%A Vukashinovic, V.
%A Zalunin, I.A.
%A Timokhina, E.A.
%A Lavrenova, G.I.
%A Stepanov, V.M.
%J Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
%V 113
%N 1
%P 57-62
%@ 1096-4959
%D 1996
%I Elsevier


%0 Journal Article
%T Evaluation of protein preparations from bacteria using proteomics approaches: Application to an Antarctic bacterium Pseudomonas syringae
%A Abou-Eladab, E.F.
%A Idris, M.M.
%A Jagannadham, M.V.

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

publication dr ehab aboueladab

TY  - JOUR
T1  - Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes
A1  - Brandt, B.
A1  - B├╝chse, T.
A1  - Abou-Eladab, E.F.
A1  - Tiedge, M.
A1  - Krause, E.
A1  - Jeschke, U.
A1  - Walzel, H.
JO  - Histochemistry and cell biology
VL  - 129
IS  - 5
SP  - 599
EP  - 609
SN  - 0948-6143
Y1  - 2008
PB  - Springer
ER  -


TY  - JOUR
T1  - Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes
A1  - Walzel, H.
A1  - Fahmi, A.A.
A1  - Eldesouky, M.A.
A1  - Abou-Eladab, E.F.
A1  - Waitz, G.
A1  - Brock, J.
A1  - Tiedge, M.
JO  - Glycobiology
VL  - 16
IS  - 12
SP  - 1262
EP  - 1271
SN  - 0959-6658
Y1  - 2006
PB  - Soc Glycobiology
ER  -


TY  - JOUR
T1  - Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
A1  - Brandt, B.
A1  - Abou-Eladab, EF
A1  - Tiedge, M.
A1  - Walzel, H.
JO  - Cell death & disease
VL  - 1
IS  - 2
SP  - e23
Y1  - 2010
PB  - Nature Publishing Group
ER  -


TY  - JOUR
T1  - Identification of outer membrane proteins from an Antarctic bacterium Pseudomonas syringae Lz4W
A1  - Jagannadham, M.V.
A1  - Abou-Eladab, E.F.
A1  - Kulkarni, H.M.
JO  - Molecular & Cellular Proteomics
VL  - 10
IS  - 6
SN  - 1535-9476
Y1  - 2011
PB  - ASBMB
ER  -


TY  - JOUR
T1  - Buffalo (< i> Bos Buffali L.</i>) chymosin purification and properties
A1  - Abdel Malak, C.A.
A1  - Abou El Adab, I.F.G.
A1  - Vukashinovic, V.
A1  - Zalunin, I.A.
A1  - Timokhina, E.A.
A1  - Lavrenova, G.I.
A1  - Stepanov, V.M.
JO  - Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
VL  - 113
IS  - 1
SP  - 57
EP  - 62
SN  - 1096-4959
Y1  - 1996
PB  - Elsevier
ER  -


TY  - JOUR
T1  - Evaluation of protein preparations from bacteria using proteomics approaches: Application to an Antarctic bacterium Pseudomonas syringae
A1  - Abou-Eladab, E.F.
A1  - Idris, M.M.
A1  - Jagannadham, M.V.
ER  -

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

E=mc² is Incomplete

------------------------------------------Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

الوطن | الكساد يضرب دمياط ليلة "الأضحى"..والمواطنون عصر "مرسي" أسوأ من "مبارك"

الوطن | الكساد يضرب دمياط ليلة "الأضحى"..والمواطنون عصر "مرسي" أسوأ من "مبارك"

------------------------------------------Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

نهر الأمازون يقع في أمريكا الجنوبية

 نهر الأمازون يقع في أمريكا الجنوبية. وهو أكبر نهر في العالم من حيث الحجم والعمق، ومن حيث معدل التدفق الذي يفوق معدل تدفق أكبر ثماني أنهار في العالم الذين يلونه في الترتيب مجتمعين.

يزداد اتساع أجزاء من الأمازون عن 190 كيلومتر (120 ميل) أثناء موسم الأمطار. ونظرا لاتساعه يطلق عليه أحيانا البحر النهر.

في حين أن نهر الأمازون هو أغزر نهر في العالم، إلا أن البيانات الحالية للجمعية الجغرافية تشير إلى أن الأمازون هو ثاني أطول نهر في العالم بعد نهر النيل. ومع ذلك يجادل بعض العلماء خاصة من البرازيل وبيرو بخصوص ذلك.

------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

Diabetes Mellitus

Q.1- What is the biochemical basis for the followings in Diabetes Mellitus-

a) Weight loss

b) Paresthesias

c) Increased susceptibility to infections

d) Non healing ulcers

e) Blindness

f) Hypoglycemia

g) Lactic acidosis

h) Ketosis

i) Hypercholesterolemia

j) High risk for IHD

Q- 2 What is Glycated hemoglobin? What is its significance in the diagnosis of Diabetes mellitus?

Q.3- What is the cause of Hypokalemia upon insulin administration in diabetics?

Q.4.- What is Maturity onset diabetes mellitus of young (MODY)?

Q.5-What is LADA (Latent Auto immune diabetes mellitus of Adults)?

Q.6- What are the important differences between Type1 and Type 2 diabetes mellitus?

Q.7- What is the cause of insulin resistance in type 2 diabetes mellitus?

Q.8-A 35 year- old woman reported with classical symptoms of polyuria, Polyphagia and Polydipsia. Her fasting blood glucose was 190 mg/dl. She was diagnosed witDiabetes mellitus and was started with oral hypoglycemic drugs. A week laterher blood glucose was repeated and was found to be 234 mg/dl.  What could be the reason for increasing blood glucose level despite glucose lowering therapy? Which investigation should bcarried out for further diagnosis?

Q.9-What is the significance of estimating c-peptide levels?

Q.10- What are diabetes prone states?

Q.11-What are the secondary causes of diabetes mellitus?

Q.12- What is the significance of detecting microalbuminuria in diabetes mellitus?

Q.13-What is the biochemical basis for impaired glucose uptake inskeletal muscles and adipose tissue in diabetes mellitus?

Q.14- What is the biochemical basis for complications in diabetes mellitus?

Q.15- What are the acute complications of diabetes mellitus?

Q.16-What are late onsets or chronic complications of diabetes mellitus?

Q.17-What is meant by “Advanced glycation end products”?

Q.18- What are the metabolic alterations brought about in the absence of insulin in diabetes mellitus?

Q.19- Enumerate the different tests carried out for the diagnosis of diabetes mellitus?

Q.20 Suggest a healthy diet for a diabetic patient? What is the role of dietary fiber?

Q.21- What is the treatment for diabetic ketoacidosis?

Q.22- What should be the fasting and post load blood glucose values for a person to be declared as  having impaired glucose tolerance?

Q.23- What are the indication for carrying out oral glucose tolerance test ?

Q.24 -What is the criteria for the laboratory diagnosis of diabetes mellitus after oral glucose tolerance test?

Q.25- What is the significance of serum fructosamine estimation in diabetes mellitus?

----------------------------------------- Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------